SENSIGHT is a global real world data analytics platform for the life sciences and healthcare industries providing unparalleled insights from access to patient data sets.
SENSIGHT is the first data analytics platform to provide industrial scale access to anonymised and de-identified real world data insights globally across multiple therapy areas combined with built in simple to use research algorithms.
The platform is evolving rapidly adding researchable disease areas, analytical tools and patient data towards a planned data set of 100m patients by 2024.
SENSIGHT provides researchers across life sciences, healthcare and academia with an instant, artificial intelligence enabled research capability to harness the true potential of real-world data.
The platform achieves this by delivering a simple way to derive rapid insights and informed decisions from curated deep, longitudinal, structured real world patient data without compromising patient privacy.
SENSIGHT offers a suite of sophisticated AI research tools for synthetic control arms, cohort characterisation, disease progression, patient stratification, and image report analysis.
Access to the SENSIGHT platform is on an individual subscriber basis of £25,000 per person per year for commercial customers.
Learn more about SENSIGHTSubscribe to our mailing list
Sign up to receive product updates and exclusive content - direct to your inbox!
Sensyne uses the information you provide to send you great content about relevant products and services. You may unsubscribe from these communications at any time. For more information, check out our privacy policy
SENSIGHT offers all subscribers the following:
Synthetic control arms
Analyse the feasibility of running synthetic control arms on specific patient data sets using Sensyne’s proprietary analytics tools.
Create patient cohorts
Create new patient cohorts in specific research areas across large, diverse data sets efficiently, quickly and at scale.
Patient stratification
Undertake patient stratification of cohorts to identify relevant sub-groups of patients using Sensyne’s proprietary deep clustering tools.
Image reports
Perform medical image report analyses.
Real world patient journeys
Analyse usage and outcomes by product or class across different health systems to understand real-world patient journeys.
Benefits
Reduce attrition
Reducing clinical trial attrition by quickly assessing feasibility.
Reduce cost
Reducing cost and duration of clinical trials by optimising trial design.
Drug target identification
Accelerating discovery and development of new drugs.
Refine market access
Refining market access strategies for new or existing drugs.
Identify patient cohorts
Referral support for companies interested in clinical trials
Protecting patient privacy
We know patient data is precious so protecting it is our first priority. We never share data. We never sell data. Data never leaves Sensyne.
The platform instead rapidly interrogates Sensyne’s deep diverse datasets and delivers intelligent analytics and data-driven insights, not the data itself. . It does not allow SENSIGHT users access to any patient data directly.
Single user access
With a simple subscription model, SENSIGHT is democratising health data and has the potential to accelerate clinical research. Individual researchers can analyse SENSIGHT data simply, easily and at pace.
Complex data analysis made simple
Simple to use dashboard on a single platform that enables complex research queries to be easily and quickly navigated and understood.
